BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

Clinical trial NCT05943106 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05943106
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Muscle- Invasive Bladder Cancer

Start date: 2023-08-11
Primary completion: 2025-06-16
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.